Details of the Drug Reposition

General Information of This Drug (ID: DMOUC09)

Drug Name
Norepinephrine   DMOUC09
Synonyms
norepinephrine; L-Noradrenaline; Levarterenol; 51-41-2; L-Norepinephrine; Levophed; (-)-Norepinephrine; L-arterenol; (R)-Noradrenaline; (R)-Norepinephrine; Levonor; Levonorepinephrine; Adrenor; Aktamin; Levonoradrenaline; Sympathin E; (R)-(-)-Norepinephrine; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; Noradrenalin; Norepirenamine; norepinephrinum; Noradrenalinum; Levoarterenol; Norartrinal; Nor-Epirenan; L-3,4-dihydroxyphenylethanolamine; Levarterenolo; Noreinefrina; Norepinefrina; Norepinephrinum; Levarterenolo [DCIT]; Nor adrenalin; Noradrenalina [Italian]; Norepinephrine Noradrenalin; LT03330026; ALBB-006229; Nor adrenalin (TN); Noradrenaline (JP15); Noreinefrina [INN-Spanish]; Norepinephrine (INN); Norepinephrine [INN:JAN]; Norepinephrinum [INN-Latin]; Norepinephrine l-Tartrate (1:1); D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; (-)-(R)-Norepinephrine; (-)-Arterenol free base; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; Ecteinascidins
Therapeutic Class
Vasoconstrictor Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
10 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Radiodermatitis DIS9NUJ1 N.A. Approved [1]
Pure autonomic failure DISH6N87 N.A. Approved [1]
Psychosexual disorder DISGQK8E N.A. Approved [1]
Depression DIS3XJ69 6A70-6A7Z Approved [1]
Chronic fatigue syndrome DIS34WJ5 8E49 Approved [1]
Bronchitis DISBM6EQ CA20 Approved [1]
Pulmonary emphysema DIS5M7HZ CA21.Z Approved [1]
Severe asthma DISAVQI3 CA23 Approved [1]
Bronchiectasis DIS5MYEE CA24 Approved [1]
Alopecia DIS37HU4 ED70 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Indications(s)
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hypotension DISYNSM9 BA20-BA21 Withdrawn [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Orthostatic hypotension 1 DISOXVFG N.A. Discontinued in Phase 3 [3]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Parkinson disease DISQVHKL 8A00.0 Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Sepsis DISVONJE 1G40-1G41 Investigative [5]
------------------------------------------------------------------------------------

References

1 Norepinephrine FDA Label
2 Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
3 "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
4 Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 505).